JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$870M |
| 2 |
Meta Platforms (Facebook)
META
|
+$692M |
| 3 |
Johnson & Johnson
JNJ
|
+$495M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$408M |
| 5 |
Microsoft
MSFT
|
+$390M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$790M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$736M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$699M |
| 4 |
SLB Ltd
SLB
|
+$401M |
| 5 |
THE NEWS CORPORATION LTD CL-B
NWS
|
+$346M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.89% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 10.35% |
| 4 | Technology | 10.34% |
| 5 | Energy | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SALE
276
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $255M | 0.08% |
+7,180,181
| New | +$230M |
2013 Q3
0 quarters
|
|
277
O'Reilly Automotive
ORLY
$72.1B
| $255M | 0.08% |
29,944,365
-6,575,775
| -18% | -$53.8M |
2013 Q2
1 quarter
|
|
278
CALL
Molina Healthcare
MOH
$10.8B
| $255M | 0.08% |
+7,149,825
| New | +$264M |
2013 Q3
0 quarters
|
|
279
Las Vegas Sands
LVS
$24.7B
| $254M | 0.08% |
3,817,892
+1,108,659
| +41% | +$64.3M |
2013 Q2
1 quarter
|
|
280
iShares Core S&P 500 ETF
IVV
$879B
| $253M | 0.07% |
1,495,910
+342,747
| +30% | +$57.8M |
2013 Q2
1 quarter
|
|
281
State Street Industrial Select Sector SPDR ETF
XLI
$30.5B
| $252M | 0.07% |
5,428,481
-384,888
| -7% | -$17.4M |
2013 Q2
1 quarter
|
|
282
Ventas
VTR
$43.8B
| $251M | 0.07% |
3,580,304
-72,606
| -2% | -$5.39M |
2013 Q2
1 quarter
|
|
|
SIAL
283
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $248M | 0.07% |
2,903,575
+265,808
| +10% | +$22.4M |
2013 Q2
1 quarter
|
|
284
Aptiv
APTV
$9.33B
| $247M | 0.07% |
4,224,915
+3,142,431
| +290% | +$175M |
2013 Q2
1 quarter
|
|
285
iShares MSCI Brazil ETF
EWZ
$11.7B
| $246M | 0.07% |
5,124,511
-2,689,340
| -34% | -$120M |
2013 Q2
1 quarter
|
|
286
Prologis
PLD
$119B
| $244M | 0.07% |
6,490,871
+416,187
| +7% | +$15.7M |
2013 Q2
1 quarter
|
|
287
DELISTED
Staples Inc
SPLS
| $242M | 0.07% |
16,548,938
+15,445
| +0.1% | +$242K |
2013 Q2
1 quarter
|
|
|
AGN
288
DELISTED
Allergan plc
AGN
| $241M | 0.07% |
1,670,799
+221,974
| +15% | +$29.6M |
2013 Q2
1 quarter
|
|
|
CFN
289
DELISTED
CAREFUSION CORPORATION
CFN
| $240M | 0.07% |
6,510,641
-2,549,053
| -28% | -$95.2M |
2013 Q2
1 quarter
|
|
290
DELISTED
BEAM INC COM STK (DE)
BEAM
| $239M | 0.07% |
3,698,380
-303,628
| -8% | -$19.5M |
2013 Q2
1 quarter
|
|
291
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $235M | 0.07% |
13,470,356
-16,285,847
| -55% | -$289M |
2013 Q2
1 quarter
|
|
292
SPX Corp
SPXC
$8.29B
| $234M | 0.07% |
10,955,862
-482,286
| -4% | -$9.37M |
2013 Q2
1 quarter
|
|
293
Lennar Class A
LEN
$18.2B
| $230M | 0.07% |
6,816,555
-60,805
| -0.9% | -$1.97M |
2013 Q2
1 quarter
|
|
294
DELISTED
PALL CORP
PLL
| $228M | 0.07% |
2,963,811
+313,763
| +12% | +$22.5M |
2013 Q2
1 quarter
|
|
295
lululemon athletica
LULU
$11.2B
| $227M | 0.07% |
3,109,225
-470,108
| -13% | -$32.8M |
2013 Q2
1 quarter
|
|
296
Macy's
M
$6.33B
| $227M | 0.07% |
5,253,018
-1,165,530
| -18% | -$54.4M |
2013 Q2
1 quarter
|
|
297
EQT Corp
EQT
$33.9B
| $227M | 0.07% |
4,706,232
-478,609
| -9% | -$22.2M |
2013 Q2
1 quarter
|
|
298
Cardinal Health
CAH
$58.5B
| $227M | 0.07% |
4,350,162
-2,130,720
| -33% | -$108M |
2013 Q2
1 quarter
|
|
299
W.R. Berkley
WRB
$27.6B
| $227M | 0.07% |
17,858,894
-283,368
| -2% | -$3.55M |
2013 Q2
1 quarter
|
|
|
FRC
300
DELISTED
First Republic Bank
FRC
| $227M | 0.07% |
4,862,934
+43,998
| +0.9% | +$1.93M |
2013 Q2
1 quarter
|
|
Similar funds
JP Morgan Chase's Q3 2013 Portfolio in Review
As of Q3 2013, JP Morgan Chase held 4,631 positions worth $337B, up 7.6% from $314B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase's Q3 2013 filing shows 262 new, 1,958 increased, 1,721 reduced and 269 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 9,682,912 shares worth $323M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $790M.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 9,682,912 shares worth $323M.
- JP Morgan Chase added most to iShares MSCI EAFE ETF in Q3 2013, an estimated $870M increase.
- JP Morgan Chase's biggest Q3 2013 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $790M.
- JP Morgan Chase fully exited THE NEWS CORPORATION LTD CL-B in Q3 2013, selling an estimated $346M.
- JP Morgan Chase's ten largest holdings make up 15% of its $337B portfolio in Q3 2013.
- JP Morgan Chase opened 262 new positions and closed 269 in Q3 2013.
- JP Morgan Chase's portfolio value rose 7.6% quarter-over-quarter to $337B.
Based on JP Morgan Chase's 13F filing for Q3 2013, filed 31 Oct 2013.